MRKR – Marker Therapeutics Inc
Float Short %
5.57
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.08
EPS Last/This Y
0.11
EPS This/Next Y
0.49
Price
1.31
Target Price
6
Analyst Recom
1
Performance Q
14.16
Relative Volume
0.08
Beta
1.55
Ticker: MRKR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | MRKR | 1.56 | N/A | N/A | 0 |
| 2025-07-28 | MRKR | 1.5576 | N/A | N/A | 0 |
| 2025-07-29 | MRKR | 1.42 | N/A | N/A | 0 |
| 2025-07-30 | MRKR | 1.38 | N/A | N/A | 0 |
| 2025-07-31 | MRKR | 1.41 | N/A | N/A | 0 |
| 2025-08-01 | MRKR | 1.36 | N/A | N/A | 0 |
| 2025-08-04 | MRKR | 1.22 | N/A | N/A | 0 |
| 2025-08-05 | MRKR | 1.26 | N/A | N/A | 0 |
| 2025-08-06 | MRKR | 1.195 | N/A | N/A | 0 |
| 2025-08-07 | MRKR | 1.23 | N/A | N/A | 0 |
| 2025-08-08 | MRKR | 1.19 | N/A | N/A | 0 |
| 2025-08-11 | MRKR | 1.188 | N/A | N/A | 0 |
| 2025-08-12 | MRKR | 1.273 | N/A | N/A | 0 |
| 2025-08-13 | MRKR | 1.295 | N/A | N/A | 0 |
| 2025-08-14 | MRKR | 1.24 | N/A | N/A | 0 |
| 2025-08-15 | MRKR | 1.233 | N/A | N/A | 0 |
| 2025-08-18 | MRKR | 1.215 | N/A | N/A | 0 |
| 2025-08-19 | MRKR | 1.125 | N/A | N/A | 0 |
| 2025-08-20 | MRKR | 1.15 | N/A | N/A | 0 |
| 2025-08-21 | MRKR | 1.22 | N/A | N/A | 0 |
| 2025-08-22 | MRKR | 1.31 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | MRKR | 1.56 | -8.0 | - | -1.19 |
| 2025-07-28 | MRKR | 1.52 | -8.0 | - | -1.19 |
| 2025-07-29 | MRKR | 1.41 | -8.0 | - | -1.19 |
| 2025-07-30 | MRKR | 1.38 | -8.0 | - | -1.19 |
| 2025-07-31 | MRKR | 1.40 | -8.0 | - | -1.19 |
| 2025-08-01 | MRKR | 1.35 | -8.0 | - | -1.19 |
| 2025-08-04 | MRKR | 1.24 | -8.0 | - | -1.19 |
| 2025-08-05 | MRKR | 1.25 | -8.0 | - | -1.19 |
| 2025-08-06 | MRKR | 1.21 | -8.0 | - | -1.19 |
| 2025-08-07 | MRKR | 1.23 | -8.0 | - | -1.19 |
| 2025-08-08 | MRKR | 1.19 | -8.0 | - | -1.19 |
| 2025-08-11 | MRKR | 1.18 | -8.0 | - | -1.19 |
| 2025-08-12 | MRKR | 1.27 | -8.0 | - | -1.19 |
| 2025-08-13 | MRKR | 1.29 | -8.0 | - | -1.19 |
| 2025-08-14 | MRKR | 1.26 | -8.0 | - | -1.19 |
| 2025-08-15 | MRKR | 1.24 | -8.0 | - | -1.19 |
| 2025-08-18 | MRKR | 1.22 | -8.0 | - | -1.19 |
| 2025-08-19 | MRKR | 1.13 | -8.0 | - | -1.19 |
| 2025-08-20 | MRKR | 1.15 | -8.0 | - | -1.19 |
| 2025-08-21 | MRKR | 1.22 | -8.0 | - | -1.19 |
| 2025-08-22 | MRKR | 1.31 | 19.2 | - | -1.08 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-07-28 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-07-29 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-07-30 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-07-31 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-01 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-04 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-05 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-06 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-07 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-08 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-11 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-12 | MRKR | 0.00 | -13.58 | 6.37 |
| 2025-08-13 | MRKR | 0.00 | -13.58 | 6.37 |
| 2025-08-14 | MRKR | 0.00 | -13.58 | 6.37 |
| 2025-08-15 | MRKR | 0.00 | -13.58 | 6.37 |
| 2025-08-18 | MRKR | 0.00 | -15.12 | 6.37 |
| 2025-08-19 | MRKR | 0.00 | -15.12 | 5.57 |
| 2025-08-20 | MRKR | 0.00 | -15.12 | 5.57 |
| 2025-08-21 | MRKR | 0.00 | -15.12 | 5.57 |
| 2025-08-22 | MRKR | 0.00 | -15.12 | 5.57 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.29
Avg. EPS Est. Current Quarter
-0.21
Avg. EPS Est. Next Quarter
-0.21
Insider Transactions
Institutional Transactions
-15.12
Beta
1.55
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
18
Growth Score
28
Sentiment Score
14
Actual DrawDown %
96.5
Max Drawdown 5-Year %
-98
Target Price
6
P/E
Forward P/E
PEG
P/S
3.1
P/B
1.39
P/Free Cash Flow
EPS
-1.37
Average EPS Est. Cur. Y
-1.08
EPS Next Y. (Est.)
-0.59
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-271.11
Relative Volume
0.08
Return on Equity vs Sector %
-163.9
Return on Equity vs Industry %
-151
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.11
EBIT Estimation
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading